Procalcitonin levels in COVID-19 patients-Reference-Cited by-同舟云学术

Procalcitonin levels in COVID-19 patients

Published:2020-08 Issue:2 Volume:56 Page:106051
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Hu Rui,Han Chaofei,Pei Shiyao,Yin Mingzhu^ORCID,Chen Xiang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation report – 124.https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200523-covid-19-sitrep-124.pdf?sfvrsn=9626d639_2[accessed 24 May 2020].

2. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020

3. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China;Zhang;Allergy,2020

4. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

5. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Procalcitonin in inflammatory bowel disease: A diagnostic or prognostic marker;Pathology - Research and Practice;2024-10

2. Biomarkers of COVID-19 short-term worsening: a multiparameter analysis within the prospective multicenter COVIDeF cohort;European Journal of Emergency Medicine;2024-09-12

3. Association of antibiotics with the outcomes in COVID-19 pneumonia patients with elevated PCT levels;Respiratory Medicine;2024-09

4. The clinical characteristics analysis of serum markers for the cardiovascular system in early-stage COVID-19 patients;Frontiers in Cardiovascular Medicine;2024-07-26

5. The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19;eBioMedicine;2024-07